Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...
Tirzepatide fallout in The Hill
The Hill covers the fallout from the FDA’s taking tirzepatide off the shortage list — especially how compounders are pushing back — in “Rivals fight for right to sell weight loss drugs.” Of course it quotes APC:
Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said in a press briefing that “a lot of patients have been left flat footed” by the FDA ending the shortage.
